2016 | Preclinical investigation of Ibrutinib, a Bruton’s kinase tyrosine (Btk) inhibitor, in suppressing glioma tumorigenesis and stem cell phenotypes | Wei, L; Su, YK; Lin, CM; Chao, TY; Huynh, TT; Jan, HJ; Whang-Peng, J; Chiou, JF; Wu, AT; Hsiao, M | Oncotarget 7(43), 69961-975 | | | |
2018 | Serum amyloid A1 in combination with integrin αVβ3 increases glioblastoma cells mobility and progression | Lin, CY; Yang, ST; Shen, SC; Hsieh, YC; Hsu, FT; Chen, CY; Chiang, YH; Chuang, JY; Chen, KY; Hsu, TI; Leong, WC; Su, YK; Lo, WL; Yeh, YS; Patria, YN; Shih, HM ; Chang, CC; Chou, SY | Molecular Oncology 12(5), 756-771 | | | |